On 20th November, PHE published a joint letter from NHS England and DHSE, giving guidance to pharmacists and GPs for the ordering of flu vaccines for 2019/20. Following this letter, guidance has been changed.
Guidance includes the following:
- Standard Trivalent vaccines (TIV) are NOT to be used in the next season
- Quadrivalent inactivated vaccine (QIVe) and adjuvanted trivalent inactivated vaccine (aTIV) from the current scheme will continue to be recommended for use, again QIVe is recommended for 18-64s in at risk groups and aTIV for over 65’s
In addition, it was anticipated that a further two products would be licensed for use during the ordering window.
The cell-based quadrivalent vaccine, QIVc, (suitable for 18 to 64 years and 65 years+) has been deemed suitable for the vaccination service 2019/2020. Flucelvax® Tetra, is now licensed for use and contractors can consider ordering this for 2019/20 Flu Vaccination Service.
However, the a high dose trivalent vaccine (TIV-HD) (suitable for 65 years and over) will NOT be commissioned by NHSE due to the high sale price. Although licensed , you are advised NOT to purchase this product for the Advanced flu service as it will not be reimbursed.
Read the joint letter ALONGSIDE updated guidance before you make any decisions on ordering for next year’s service.